Antacids Global Market Report 2024

Antacid drugs are medications used to neutralize stomach acid, providing relief from conditions such as acid reflux, heartburn, and indigestion. They counteract the stomach's acid, easing symptoms, and are available without a prescription in liquid or chewable tablet form. The drug classes within antacids include proton pump inhibitors, H2 antagonists, surgical simulators, and acid neutralizers, available in tablets, liquid, or powder forms.

The primary classes of antacids are proton pump inhibitors, H2 antagonists, acid neutralizers, and pro-motility agents. Proton pump inhibitors significantly and for an extended period reduce stomach acid production by irreversibly blocking the H+/K+ ATPase proton pump in the stomach. Antacids come in various formulations, including tablets, liquids, powders, and others, and are distributed through channels such as hospital pharmacies, retail pharmacies, and other outlets.

The antacids market research report is one of a series of new reports from The Business Research Company that provides antacids market statistics, including antacids industry global market size, regional shares, competitors with an antacids market share, detailed antacids market segments, market trends, and opportunities, and any further data you may need to thrive in the antacids industry. This antacids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antacids market size has grown steadily in recent years. It will grow from $9.16 billion in 2023 to $9.52 billion in 2024 at a compound annual growth rate (CAGR) of 3.9%. The growth observed during the historical period in the antacids market can be attributed to factors such as historical pricing and accessibility of antacid medications, shifts in dietary habits over time, economic conditions and lifestyle changes influencing healthcare choices, advancements in medical understanding and awareness of gastrointestinal conditions, and historical population demographics shaping the prevalence of acid-related issues.

The antacids market size is expected to see steady growth in the next few years. It will grow to $11 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The anticipated growth in the forecast period in the antacids market can be attributed to factors such as market competition and industry trends, evolving consumer preferences and brand loyalty, environmental considerations and lifestyle changes affecting health choices, the emergence of new health conditions, and economic conditions influencing healthcare spending. Major trends expected in the forecast period include increased health consciousness and awareness among consumers, technological advancements in antacid formulations, a preference for natural remedies, regulatory changes and compliance in the pharmaceutical industry, and a rising incidence of digestive disorders contributing to the demand for antacid medications.

The growth of the antacids market is significantly influenced by poor lifestyle choices, leading to a higher prevalence of acidity. Unhealthy lifestyle practices, such as sedentary jobs, inadequate sleep quality, and irregular dietary habits, contribute to elevated stomach acidity levels, resulting in conditions such as gastroesophageal reflux disease (GERD). The American College of Gastroenterology reports that approximately 60 million Americans suffer from GERD, fueling the demand for antacids.

The anticipated increase in the prevalence of inflammatory bowel disease is expected to drive the growth of the animal growth promoters and performance enhancers market. Inflammatory bowel disease (IBD) encompasses a group of conditions characterized by chronic inflammation in the digestive tract. Antacids, designed to regulate stomach acid levels, are commonly used for managing heartburn and indigestion. According to the International Foundation for Gastrointestinal Disorders (IFFGD), it is projected that 5-10% of the global population will have irritable bowel syndrome (IBS) by 2023, affecting between 25 and 45 million people in the United States. Additionally, a survey by the American Gastroenterological Association covering 33 countries on 6 continents revealed that more than 40% of adult respondents worldwide have functional gastrointestinal disorders (FGID), impacting their quality of life and healthcare utilization. Consequently, the increasing prevalence of inflammatory bowel disease is expected to propel the growth of the animal growth promoters and performance enhancers market in the future.

The antacids market faces a major restraint in the form of side effects associated with these medications. Common side effects include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may lead to issues such as constipation, aluminum intoxication, osteomalacia, and hypophosphatemia. Additionally, when consumed with other acidic drugs, antacids may result in reduced efficacy of both drugs due to drug absorption interactions.

An emerging trend in the antacid market is the development of mouth-melting antacids. Traditionally available in tablet, liquid, and powder forms, mouth-melting antacids utilize micro-mouth melting granules that easily dissolve in the mouth. Sunpharma's 'Pepmelt' is an example of a mouth-melting instant relief antacid that combines herbal constituents with contemporary mouth-melting technology.

Major companies in the antacids market are diversifying their product offerings by introducing multiple antacid flavors to enhance market profitability. Antacid flavors refer to the various tastes available for antacid products. Wonderbelly, a US-based digestive medicine company, introduced three antacid flavors, namely Fruity Cereal (exclusive to Target stores), Strawberry Milkshake, and Watermelon Mint, in March 2023. Wonderbelly's Antacid, containing calcium carbonate as its active ingredient, distinguishes itself as a non-GMO and vegan product without talc, dyes, gluten, dairy, common allergens, synthetic sweeteners, artificial flavors, parabens, and preservatives. Developed in collaboration with gastroenterologists and pharmaceutical manufacturers, these products prioritize quality.

In the United States, manufacturers of antacids are required to comply with the Code of Federal Regulations Title 21 established by the FDA. According to these regulations, over-the-counter (OTC) antacid products in forms suitable for oral administration are deemed safe and effective only if they meet the conditions related to active ingredients specified by the FDA.

Major companies operating in the antacids market report are Walmart Equate LLC, Private Label, Pfizer Inc., Johnson & Johnson Services Inc., Procter & Gamble Co., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation, Xiuzheng Pharmaceutical Group Company Limited, Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Alkem Laboratories Ltd., Conba Group Co. Ltd., Chattem Chemicals Inc., China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Thornton and Ross Ltd., McNeil Consumer Pharmaceuticals Co., Advance Pharmaceutical Inc.

North America was the largest region in the antacids market in 2023. The Middle East is expected to be the fastest-growing region in the global antacids market share. The regions covered in the antacids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antacids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The antacids market consists of sales of Alka Seltzer, Maalox, Mylanta, Rolaids, Tums, and Pepto-Bismol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antacids Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antacids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antacids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antacids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Class: Proton Pump Inhibitors; H2 Antagonist; Acid Neutralizers; Pro-Motility Agents
• 2) By Formulation Type: Tablet; Liquid; Powder; Other Formulation Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• Companies Mentioned: Walmart Equate LLC; Private Label; Pfizer Inc; Johnson & Johnson Services Inc.; Procter & Gamble Co.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.